Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial

Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Site footer updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:27:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T17:56:31.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T16:31:45.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The lapse in government funding notice and the prior v3.4.1 revision note were removed, and the revision history was updated.
    Difference
    0.4%
    Check dated 2026-02-11T02:42:17.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s status, along with a version update from 3.4.0 to 3.4.1, were added.
    Difference
    0.4%
    Check dated 2026-02-04T00:23:15.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A glossary display was added to improve understanding of terms on the study page. In addition, there are minor text and version updates (new QC criteria label and Revision: v3.4.0) and removal of similar old labels.
    Difference
    0.2%
    Check dated 2026-01-27T23:56:23.000Z thumbnail image

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.